Newsletters - June 1998

Newsletters - June 1998

Sabinsa Corporation was assigned a second patent on its trademarked standardized black pepper extract, Bioperine(R), by the U.S. Patents and Trademarks office.

The first patent on the use of Bioperine® as an enhancer of nutrient bioavailability, (U.S. Patent 5,536,506) was issued in 1996. Patent 5,744,161 dated April 28, 1998, covers the use of piperine as a bioavailability enhancer for a broader range of nutritional supplements.

The salient features of the oral, topical and parenteral compositions with piperine described in the patent, include increased gastrointestinal absorption and improved transfer of nutrients / biological compounds through various biological membrane barriers in the body, as well as enhanced systemic utilization of these compounds. The patent also describes a new process for the extraction and purification of piperine.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.